One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Non-medical switching in dermatology: cost-conscious policy or an affront to patient safety?
Palak V. Patel, Caitlin G. Purvis, Ramiz N. Hamid & Steven R. Feldman
doi : 10.1080/09546634.2022.2110360
Journal of Dermatological Treatment, Volume 33, Issue 6 (2022)
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses
Jonwei Hwang, Jonathan Rick, Jennifer Hsiao & Vivian Y. Shi
doi : 10.1080/09546634.2022.2067819
IL-36 cytokines are members of the IL-1 superfamily. Increasing evidence in the IL-36 pathway demonstrates their potential as a therapeutic target for treating inflammatory skin diseases, such as generalized pustular psoriasis (GPP).
Methylprednisolone and local anesthetic for long-term postherpetic neuralgia: a meta-analysis
Yuan Zhang, Ye-Lin Gao & Li-Hua Zhang
doi : 10.1080/09546634.2022.2067820
The purpose was to evaluate the efficacy of methylprednisolone combined with local anesthetics on the incidence or intensity of long-term Postherpetic neuralgia (PHN).
Communicating with patients through pictograms and pictures – a scoping review
Farnam Barati Sedeh, Mattias Arvid Simon Henning, Ole Steen Mortensen,Gregor Borut Ernst Jemec & Kristina Sophie Ibler
doi : 10.1080/09546634.2022.2068790
Communication between patients and healthcare workers (HCWs) may on occasion be challenged by disparities in cultural background, age and educational level. Written educational material is commonly used to reduce the risk of miscommunication. However, literacy among patients may also differ and it is, therefore, speculated that the use of pictograms may improve patients’ understanding and adherence.
Benefits, drawbacks, and challenges of social media use in dermatology: a systematic review
Leire Barrutia, Jesús Vega-Gutiérrez & Alba Santamarina-Albertos
doi : 10.1080/09546634.2022.2069661
The presence of dermatological information on social media has grown exponentially over the last two decades. Consequently, the recent literature on this topic is abundant. Many authors have highlighted that social media constitutes a unique opportunity for patient education. Additionally, numerous other benefits of these platforms have been reported. However, other authors have focused on the potential risks that these networks involve.
Uses of eye drops in dermatology, literature review
Sameh Magdy Sarsik & Heba Saed El-Amawy
doi : 10.1080/09546634.2022.2079598
Background: Since medication absorption through the skin and eye tissue seems similar, commercially available eye-drops could be used to treat skin diseases when topical therapies are unavailable or unaffordable. The FDA-approved and off-label applications of various eye drops used as topical treatments in dermatological clinical practice were highlighted in this review.
Evidence-based clinical practice guidelines for the management of psoriasis: systematic review, critical appraisal, and quality assessment with the AGREE II instrument
Mohamed Ali Babiker Mohamed, Ahmed M. El-Malky, Wael AhmedAbdelwahab Abdelkarim, Mohamed Abdulmonem Salih Aabdeen, TarigHassan Elobid Ahmed, Hassan H. H. Sarsour, Munirah Mohammed Mosa,Yasser S. Amer, Abdulrahman Ali M. Khormi & Abdulmajeed Alajlan
doi : 10.1080/09546634.2022.2083545
Psoriasis is considered one of the stubborn lifelong dermatologic diseases, making the patients seized in their social cage. Evidence-based clinical practice guidelines (CPGs) and expert opinions ensure that patients with psoriasis render the most recent and developed care. This systematic review assessed and compared the most recently approved international CPGs with the AGREE II instrument.
Killing all the birds with one drug – is oral roflumilast a novel treatment option for psoriasis?
Mette Gyldenløve & Alexander Egeberg
doi : 10.1080/09546634.2022.2069223
Psoriasis is a common, chronic inflammatory skin disease associated with a large number of comorbidities. Though management of moderate-to-severe plaque psoriasis has greatly improved in recent years, patients with refractory disease or contraindications to available treatments still constitute therapeutic challenges. Oral roflumilast, a selective phosphodiesterase-4 (PDE-4) inhibitor, is approved for chronic obstructive pulmonary disease.
Internet-based survey intervention improves adherence to methotrexate among psoriasis patients
Abigail Cline, Emily L. Unrue, Leah A. Cardwell, Hossein Alinia, Rechelle Tull,Steven R. Feldman & William W. Huang
doi : 10.1080/09546634.2022.2071821
While it is known that psoriasis patients have poor adherence to both topical and systemic medications, adherence to methotrexate is not well-characterized, and ways to improve methotrexate adherence have not been addressed.
Efficacy and tolerability of three topical acne treatments by body mass index: post hoc analysis including overweight and obese patients
Jonette Keri, Fran E. Cook-Bolden, Lawrence Green, Leon H. Kircik, HilaryBaldwin, William Philip Werschler, Eric Guenin, Radhakrishnan Pillai &Varsha Bhatt
doi : 10.1080/09546634.2022.2071823
Acne prevalence may be higher in overweight/obese individuals, potentially due to hormonal, inflammatory, and/or dietary factors. However, the effects of body mass index (BMI) on topical acne treatments are largely unknown.
The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis
Yajia Li, Beisi Zhang, Jia Guo, Ziqin Cao & Minxue Shen
doi : 10.1080/09546634.2022.2080170
There is a lack of certain evidence for the therapeutic efficacy of probiotics for adult atopic dermatitis (AD).
Future prospects in 3-dimensional (3D) technology and Mohs micrographic surgery
Stephanie Ishack & Amor Khachemoune
doi : 10.1080/09546634.2022.2080171
The advancement of three-dimensional (3D) bioprinting has allowed for changes within the field of dermatology. Skin bioprinting is a transformative technology used to fabricate biomimetic scaffold architectures which mimic human skin.
Real-world practice indirect comparison between guselkumab, risankizumab, and tildrakizumab: results from an Italian 28-week retrospective study
Matteo Megna, Nello Tommasino, Luca Potestio, Teresa Battista, AngeloRuggiero, Matteo Noto, Gabriella Fabbrocini & Lucia Genco
doi : 10.1080/09546634.2022.2081655
Guselkumab, tildrakizumab, and risankizumab, acting on interleukin(IL)23 axis, have been recently approved for psoriasis management. However, real-life data regarding their comparison are scant.
Therapeutic failure in moderate and severe psoriasis patients in a health institution – a transversal study of prevalence and demographic determinants
Daniel Montoya-Londoño, Carlos Alberto Gómez-Mercado, Jorge IvánEstrada-Acevedo, Juliana Madrigal-Cadavid, Angela Segura, Newar AndrésGiraldo-Alzate & Angela MarÃa Londoño
doi : 10.1080/09546634.2022.2079597
Psoriasis is a chronic disease that seriously impacts quality of life. There are known genetic and environmental factors that influence its onset and progression. Even though there is no cure for it, there are a variety of treatments available today to control its symptoms, although many of them fail to do so substantially.
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors – brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry
Martina Kojanova, Jan Hugo, Barbora Velackova, Petra Cetkovska, JorgaFialova, Tomas Dolezal, Martin Tichy & Spyridon Gkalpakiotison behalf ofthe BIOREP study group
doi : 10.1080/09546634.2022.2082354
Real-world data on the use of interleukin-17 (IL-17) inhibitors for the treatment of psoriasis are limited.
Kaposi’s sarcoma management from a plastic surgery perspective
Selman Taskin, Tugce Yasak, S. Tiber Mentese, Burak Yilmaz & Ozlem Çolak
doi : 10.1080/09546634.2022.2083544
Kaposi's sarcoma (KS) is a low-grade angioproliferative tumor arising from endothelial cells and associated with Human Herpes Virus 8 infection. Although there are considerable number of patients referred for surgical excision, the plastic surgery literature on KS is exceptionally scarce. In this study, it was aimed to emphasize the differences in the management of Kaposi's Sarcoma and help to understand the importance of a multidisciplinary approach, accordingly the sake of choosing the ideal treatment method for each lesion.
Real-world health outcomes in US adult patients with mild to moderate plaque psoriasis taking topical therapy
David Kaplan, James Hetherington, James Lucas, Ibrahim Khilfeh & TaraNazareth
doi : 10.1080/09546634.2022.2085862
Limited health outcomes information exists for patients with mild to moderate plaque psoriasis (hereafter, referred to as psoriasis) prescribed topical treatment(s).
Efficacy evaluation and dermoscopy predictors of photodynamic therapy with different pretreatments in the treatment of actinic keratosis
Tingting Wang, Qi Han, Wenlong Hu & Hong Ren
doi : 10.1080/09546634.2022.2089325
The aim of this study was to accurately evaluate the efficacy of photodynamic therapy (PDT) on actinic keratosis (AK) in the Asian population and its relationship with preconditioning and dermoscopy grading, and to determine whether some dermoscopic features of AK can independently predict the response to PDT to optimize the choice of clinical treatment.
Omalizumab is not just an anti-immunoglobulin E
Goknur Ozaydin-Yavuz, Ibrahim Halil Yavuz, Hüseyin Serhat İnalöz & CagdasBoyvadoglu
doi : 10.1080/09546634.2022.2089326
The mechanism of omalizumab in urticaria is not literally known. Omalizumab may affect receptors on the mast cell surface in other ways, especially other than Fc epsilon RI.
Efficacy of adalimumab in pediatric generalized pustular psoriasis: case series and literature review
Yaxin Du, Qiao Yan, Mei Chen, Zhengbang Dong & Fei Wang
doi : 10.1080/09546634.2022.2089327
Generalized pustular psoriasis (GPP) is a rare, severe, and sometimes fatal form of childhood psoriasis. The first line therapies include acitretin, cyclosporin A, and methotrexate which take effect slowly and have varying long-term side effects for children. Recently, the anti-tumor necrosis factor-alpha (TNF-α), adalimumab has shown efficacy in adult patients with pustular psoriasis; however, there is lack of evidence of its usage in the pediatric population.
Racial disparities in the management of skin ulcers: an analysis of the National Ambulatory Medical Care Survey, 2012–2018
Isabelle H. Moseley, Sara D. Ragi & Adriana Lombardi
doi : 10.1080/09546634.2022.2067821
Racial/ethnic differences in health care are pervasive in the USA, but the literature is limited with regards to racial disparities in the treatment of dermatologic diseases.
Tofacitinib in the treatment of refractory eczemas – a case series
Prasanna Duraisamy, Soumya Jagadeesan & Jacob Thomas
doi : 10.1080/09546634.2022.2082355
Janus Kinase inhibitors have been shown to be effective in the treatment of various dermatoses such as alopecia areata, psoriasis, vitiligo and atopic dermatitis. The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is a common junction for the signaling of several dermatologically significant cytokines and the inhibition of this pathway by JAK inhibitors may be broadly useful in the treatment of various other dermatological disorders.
Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment
Nelson Ugwu, Shayan Cheraghlou, Hao Feng & Jeffrey M. Cohen
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group
Elena del Alcázar, Anna López-Ferrer, Ã�lvaro MartÃnez-Doménech, Marc Julià ,Ricardo Ruiz-Villaverde, Lourdes RodrÃguez Fernández-Freire, Jaime Notario,Mar Llamas-Velasco, Marta Ferran & José Manuel Carrascosa
Janus kinase inhibitors and risk of internal malignancy in dermatomyositis
Antonio Ji-Xu, Stephanie T. Le & Emanual Maverakis
